JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8419 Doxapram HCl

Summary: Potassium channel inhibitor

≥20.05 mg/mL
A8806 TMP269

Summary: HDAC 4/5/7/9 inhibitor

≥23 mg/mL
B3277 AMG 925

Target: Cyclin-Dependent Kinases|FLT3

Summary: FLT3/CDK4 inhibitor,potent and selective

insoluble in DMSO; insoluble in H2O; insoluble in EtOH
A1129 Parathyroid hormone (1-34) (human)

8 Citation

Summary: Increases blood calcium level

≥399.3 mg/mL
C6375 lenvatinib Mesylate

1 Citation

Summary: An orally active multi-target tyrosine kinase inhibitor of VEGFR2, VEGFR3, FGFR, and PDGFR for angiogenesis and hepatocellular carcinoma

≥12.53 mg/mL
B6136 Chlormadinone acetate

Summary: steroidal progestin with additional antiandrogen and antigonadotropic effects

≥17.13 mg/mL
B7806 HLCL-61

Summary: PRMT5 inhibitor

≥20.4 mg/mL
C3642 LH 21

Summary: silent CB1 antagonist

≤10 mg/mL
C4316 Bisindolylmaleimide IV

Summary: protein kinase C (PKC) inhibitor

≤20 mg/mL
C5263 LT175

Summary: dual PPARα/γ ligand

≤25 mg/mL